Cargando…
Drug treatment of coronavirus disease 2019 (COVID-19) in China.
Since December 2019, the coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread throughout China as well as other countries. More than 8,700,000 confirmed COVID-19 cases have been recorded worldwide so far, with much more cases poppi...
Autores principales: | Jin, Zhe, Liu, Jing-Yi, Feng, Rang, Ji, Lu, Jin, Zi-Li, Li, Hai-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319927/ https://www.ncbi.nlm.nih.gov/pubmed/32598953 http://dx.doi.org/10.1016/j.ejphar.2020.173326 |
Ejemplares similares
-
Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis
por: Li, Xue-Zheng, et al.
Publicado: (2020) -
Coronavirus Disease 2019 (COVID-19): A Perspective from China
por: Zu, Zi Yue, et al.
Publicado: (2020) -
Clinical Characteristics of Coronavirus Disease 2019 in China
por: Guan, Wei-jie, et al.
Publicado: (2020) -
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020) -
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020)